Literature DB >> 19443282

Use of macroporous gelatine spheres as a biodegradable scaffold for guided tissue regeneration of healthy dermis in humans: an in vivo study.

Fredrik R M Huss1, Erika Nyman, Johanna S C Bolin, Gunnar Kratz.   

Abstract

If a biodegradable scaffold is applied, the dermis can be regenerated by guided tissue regeneration. Scaffolds can stimulate in-growth of cells from the surroundings that migrate into them and start to produce autologous extracellular matrix as the scaffold is degraded. Several materials are available, but most of them are in the form of sheets and need to be laid on an open wound surface. A number of injectable fillers have been developed to correct soft-tissue defects. However, none of these has been used for guided tissue regeneration. We present a new technique that could possibly be used to correct dermal defects by using macroporous gelatine spheres as a biodegradable scaffold for guided tissue regeneration. In eight healthy volunteers, intradermal injections of macroporous gelatine spheres were compared with injections of saline and hyaluronic acid (Restylane). Full-thickness skin biopsy specimens of the implants and surrounding tissue were removed 2, 8, 12 and 26 weeks after injection, and the (immuno)histological results were analysed. The Restylane merely occupied space. It shattered the dermal tissue and compressed collagen fibres and cells at the interface between the implant and the dermis. No regeneration of tissue was found with this material at any time. The macroporous gelatine spheres were populated with fibroblasts already after 2 weeks. After 8 weeks the spheres were completely populated by fibroblasts producing dermal tissue. After 12 and 26 weeks, the gelatine spheres had been more or less completely resorbed and replaced by vascularised neodermis. There were no signs of capsular formation, rejection or adverse events in any subject. Further in vivo studies in humans are needed to evaluate the effect of the macroporous spheres fully as a matrix for guided tissue regeneration with and without cellular pre-seeding. However, the results of this study indicate the possibility of using macroporous gelatine spheres as an injectable, three-dimensional, degradable matrix for guided tissue regeneration. Copyright (c) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19443282     DOI: 10.1016/j.bjps.2009.01.068

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

1.  Optimized Repopulation of Tendon Hydrogel: Synergistic Effects of Growth Factor Combinations and Adipose-Derived Stem Cells.

Authors:  Simon Farnebo; Lovisa Farnebo; Maxwell Kim; Colin Woon; Hung Pham; James Chang
Journal:  Hand (N Y)       Date:  2016-03-15

Review 2.  Nanofiber-based delivery of bioactive agents and stem cells to bone sites.

Authors:  Zhanpeng Zhang; Jiang Hu; Peter X Ma
Journal:  Adv Drug Deliv Rev       Date:  2012-05-02       Impact factor: 15.470

3.  Biodegradable Gelatin Microcarriers Facilitate Re-Epithelialization of Human Cutaneous Wounds - An In Vitro Study in Human Skin.

Authors:  Susanna Lönnqvist; Jonathan Rakar; Kristina Briheim; Gunnar Kratz
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

4.  Ectopic osteogenesis of macroscopic tissue constructs assembled from human mesenchymal stem cell-laden microcarriers through in vitro perfusion culture.

Authors:  Maiqin Chen; Min Zhou; Zhaoyang Ye; Yan Zhou; Wen-Song Tan
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

5.  Tracking keratinocytes and melanocytes using carboxyfluorescein hydroxysuccinimidyl ester staining.

Authors:  Susanna Lönnqvist; Johan P E Junker; Maria Sedell; Erika Nyman; Gunnar Kratz
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

6.  Effect of tendon hydrogel on healing of tendon injury.

Authors:  Zheng Chen; Yongjun Rui; Yajun Xu; Quanrong Zhang; Zhenzhong Sun; Jiandong Zhou; Xueming Chen
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.